On August 11, the U.S. Centers for Disease Control and Prevention (CDC) issued updated COVID-19 guidance “to help people better understand their risk, how to protect themselves and others, what actions to take if exposed to...more
8/25/2022
/ Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Employer Liability Issues ,
Employment Policies ,
Health and Safety ,
Infectious Diseases ,
National Institute of Allergy and Infectious Diseases (NIAID) ,
OSHA ,
Vaccinations ,
Workplace Safety
For several years, policy-makers and commentators have expressed concern about the resilience of the United States’ pharmaceutical supply chain. Current U.S.-based manufacturing capabilities have been at the forefront of...more
10/8/2021
/ Biden Administration ,
Biomedical Advanced Research and Development Authority (BARDA) ,
China ,
Competition ,
Coronavirus/COVID-19 ,
Defense Production Act ,
Department of Defense (DOD) ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Manufacturers ,
NDAA ,
Pharmaceutical Industry ,
Supply Chain